MFDS — authorised 8 October 2018
- Marketing authorisation holder: ALNYLAM PHARMS INC
- Status: likely_approved
🇰🇷 Onpattro in South Korea
MFDS authorised Onpattro on 8 October 2018
Marketing authorisation
Onpattro in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Onpattro approved in South Korea?
Yes. MFDS authorised it on 8 October 2018.
Who is the marketing authorisation holder for Onpattro in South Korea?
ALNYLAM PHARMS INC holds the South Korean marketing authorisation.